Part I · Foundations & Control

01Medical Writing Is Evidence Work

Chapter 1 of 148 min read15 sources
The gist30-second version
  • Medical writing is the controlled transformation of scientific and medical information for a defined use and audience.
  • The writer must preserve fidelity to data and sources while making the result clear enough to use.
  • Fair balance requires context, limitations, countervailing evidence, and proportionate conclusions.
  • Authorship, acknowledgment, disclosure, privacy, and transparent assistance belong to the document's integrity.
  • Language quality matters, but fluent prose cannot rescue weak reasoning or unsupported claims.

The easiest way to misunderstand medical writing is to treat it as a language service. Language is central, but it is not the whole job. A document can be grammatical and elegant while still being misleading, incomplete, structurally wrong, unsuitable for its audience, or inconsistent with the underlying data. Successful medical communication joins a defined outcome and audience to sound science, applicable guidance, suitable language, and disciplined tools.1,2 Remove any one of those elements and the document weakens.

You are transforming evidence, not decorating it

Every serious medical document starts with something that exists outside the prose: a research question, protocol, dataset, statistical analysis, study report, body of literature, clinical experience, authority requirement, patient need, or program decision. The writer's task is to understand that material, decide what it can support, and transform it into a document whose form serves its purpose.1,3

That transformation involves selection. A study report cannot reproduce every row of every listing in its narrative. A manuscript cannot contain the entire clinical study report. A plain-language summary cannot retain every technical detail. Selection is unavoidable, which is why it must be principled. The writer has to decide what is material, what is background, what belongs in a visual, what needs a limitation, and what cannot safely be omitted.4

Selection also involves sequence. Readers need a path through information: why the question matters, what was done, what was found, what the findings mean, and where uncertainty remains. The sequence differs by document, but the need for a deliberate path does not.

Fidelity has two directions

Fidelity has two directions. Internal fidelity means precision and consistency inside the document: if the Methods define an objective, endpoint, or analysis, the Results must account for it, and the Results must not introduce analyses that the Methods never established.4 The abstract agrees with the body, endpoint names do not drift, numbers match across text and tables, and the conclusion reflects the results. External fidelity means accuracy against the evidence: data agree with validated outputs, claims agree with cited literature, methods agree with the protocol, and descriptions agree with the governing record.4,5

Writers often notice external errors because they look like fact-checking problems. Internal errors can be subtler. A value may be copied correctly from a source but paired with the wrong denominator elsewhere. A conclusion may be individually plausible but stronger than the Results section permits. A method may be described accurately in one section and shortened into an incompatible form in the abstract. Fidelity therefore requires both source comparison and whole-document comparison.

This is why traceability is not clerical work left for the end. If you do not know where a claim came from while drafting, you create an expensive verification problem later. If you cannot explain why a sentence exists, the sentence is not under control.

Fair balance is the working ethic

Fair balance is a defining quality of medical communication. It is not achieved by inserting one negative sentence into otherwise selective advocacy. It requires a representative account of the relevant evidence, meaningful limitations, countervailing findings, and conclusions whose strength matches the study design, results, and evidence hierarchy.4,6

The practical temptations are familiar. A preferred message arrives in the brief. One study produces an attractive result while another does not. Efficacy receives narrative space while safety is compressed. An exploratory subgroup is written as if it had been a prespecified primary question. A statistically significant result is presented without its magnitude or precision. A review cites the papers that support its direction and quietly leaves out the awkward ones.4

Fair balance resists those temptations. It asks whether the introduction represents the clinical or scientific context rather than one product alone. It asks whether methods and results stay aligned, whether safety and tolerability receive appropriate attention, whether the Discussion tests alternative explanations, and whether limitations are specific enough to change how a reader interprets the result.

Fair balance also depends on the audience. Physicians, patients, payers, policymakers, regulators, journal reviewers, investigators, and internal teams may need different detail and may judge relevance differently. Tailoring is not distortion. The same evidence can be framed differently for different readers, provided the meaning, uncertainty, and material context remain intact.

A clear sentence can still be wrong

Brevity and clarity matter, but neither is absolute. A shorter sentence is useful only if it preserves the information necessary for correct interpretation. Removing a qualifier may improve rhythm and destroy accuracy. Replacing a technical term with a familiar word may help a lay reader and introduce a false equivalence. Compressing a risk into one percentage may hide the denominator, time horizon, or comparator that gives the number meaning.4,7

Clarity begins with clear thinking. Lead with the news in short, direct, declarative sentences instead of mistaking complexity for authority.4 The Methods section is central to manuscript logic because it establishes what was done and what the Results can legitimately report. Topic sentences, parallel structure, descriptive table titles, and explicit transitions help readers follow an argument, but these devices work only when the argument itself is coherent.8,9

Clear medical prose avoids unnecessary jargon, careless word choice, ambiguous abbreviations, misplaced modifiers, and avoidable complexity.8,10 These are not cosmetic defects. A dangling modifier can attach an action to the wrong subject; a pronoun can have two plausible antecedents; and one abbreviation can carry several, even contradictory, clinical meanings.11 Editing for clarity is therefore part of accuracy.

The writer holds the whole picture

Medical writers work among specialists. Statisticians understand analysis. Clinicians understand disease and practice. Regulatory colleagues understand authority expectations. Authors and investigators understand the study. Designers understand visual communication. Patients understand the lived experience. The writer's distinctive responsibility is often integrative: to understand enough of each perspective to make the document coherent, expose missing decisions, and prevent one specialist's language from becoming misleading to another reader.3

That responsibility requires curiosity and humility. A writer should know when a term is being used inconsistently, when an endpoint does not map cleanly from protocol to results, when an author contribution is too thin for authorship, and when a statistical statement seems stronger than the design. Think like a peer reviewer during outlining and ask the difficult questions while major changes are still cheap.8 The writer should also know when to stop and ask the statistician, clinician, regulatory expert, patient representative, translator, or quality specialist.12

The senior move is not to conceal uncertainty with polished prose. It is to make the uncertainty legible and route it to the person who can resolve it.

Integrity is visible in the process

Scientific and medical integrity includes the obvious prohibitions against fabrication, falsification, and plagiarism, but it also reaches incomplete information, selective and duplicate publication, inappropriate authorship, undisclosed conflicts, unacknowledged writing support, mishandled patient information, and conclusions that outrun the data.1,4

Authorship deserves special attention because writing teams can blur contribution. The ICMJE's four criteria require substantial contribution to the work, drafting or critical revision, final approval, and — since the 2013 revision — agreement to be accountable for the work as a whole; approval alone is not a sufficient intellectual contribution.8 Contributors who do not qualify should be acknowledged appropriately. Professional medical-writing support should be transparent, including the writer's identity, employer, funding, and intellectual contribution where applicable.13 A comparative journal study found that acknowledgment of medical writers rose from 5.1% of sampled articles in 2000 to 11.3% in 2007 as disclosure practice developed.14

Privacy is equally structural. Clinical documents and patient narratives can contain information that is scientifically interesting but unnecessary for the communication purpose. Before submission, remove personal identifiers — names, addresses, initials, hospital numbers, photographs — and obtain written informed consent when specific patient details must remain.10 Include what the document needs, protect sensitive information, and remember that a data point may describe a person.15

The document is an argument under constraints

An argument does not mean advocacy regardless of evidence. It means a controlled line of reasoning. A research manuscript argues that a question mattered, that a method addressed it, that the results answer it to a stated degree, and that the interpretation follows. A regulatory overview argues that a body of evidence supports a development or approval position while accounting for limitations. A patient document argues through explanation: this is what happened, this is what it means, and this is what you may need to do.

Every argument operates under constraints. The target may prescribe sections, length, terminology, disclosures, or submission format. The study design limits causal language. The source package limits what can be claimed. The review chain limits who can approve what. The audience limits assumed knowledge. The timeline limits iteration. A professional document makes these constraints explicit enough to manage.

The section in one breathRecap
  • Begin with evidence and purpose, not prose.
  • Preserve both external fidelity to sources and internal fidelity across the document.
  • Treat fair balance as the method of representing evidence, not a disclaimer added at the end.
  • Make language clear without removing qualifications that carry scientific meaning.
  • Use the writer's integrative position to expose gaps and connect specialist perspectives.
  • Keep authorship, acknowledgment, disclosure, privacy, and assistance transparent.
  • Remember that the reader sees sentences, but quality is created by the system behind them.
Go deeperCorpus shelf
  • Writing High-Quality Medical Publications — fair balance, brevity, clarity, fidelity, ethics, authorship, disclosure, and QC.
  • Strategic Scientific and Medical Writing — the strategy/science/guidelines/language/tools model and audience-centered planning.
  • EMWA: Authors and Authorship — ghostwriting, GPP, transparency, authorship of clinical-trial documents, and publication project management.
  • AMWA Journal: Trends and Opportunities in Medical Communication — authorship acknowledgment, public trust, QC, technology, and plain-language standards.

References

Sources cited on this page, numbered in order of first appearance.

  1. Joubert PH, Rogers SM. Strategic Scientific and Medical Writing: The Road to Success. Springer; 2015.
  2. American Medical Writers Association. Ultimate Guide to Becoming a Medical Writer. American Medical Writers Association; 2022.
  3. European Medical Writers Association. EMWA Career Guide for New Medical Writers. European Medical Writers Association; 2023.
  4. Gutkin SW. Writing High-Quality Medical Publications: A User's Manual. CRC Press/Taylor & Francis; 2019.
  5. Boe P. Getting a foot in the door, then making yourself at home: additional thoughts on learning to edit pharmaceutical documents. AMWA J. 2014;29(1):13-15.
  6. Rogstad TL. Judging the quality of medical literature. AMWA J. 2009;24(4):176-181.
  7. Raynor DKT, Blackwell K, Middleton W. What do writers need to know about user testing?. Med Writ. 2015;24(4):215-218. doi:10.1179/2047480615Z.000000000327.
  8. Hindle A, Tobin SC, Robens J, McGowan D. Working with authors to develop high-quality, ethical clinical manuscripts: guidance for the professional medical writer. Med Writ. 2014;23(3):228-234.
  9. Whereat A, Leventhal PS. Structuring paragraphs. Med Writ. 2017;26(1):38-41.
  10. Stuart MC, ed. The Complete Guide to Medical Writing. Pharmaceutical Press; 2007.
  11. Davis NM. Medical abbreviations with multiple meanings: a prescription for disaster. Med Writ. 2020;29(4):16-19.
  12. Radkova E, Dobromyslov I. Best friends forever: a pattern of collaboration between medical writers and biostatisticians within the Russian CRO. Med Writ. 2016;25(3):46-49.
  13. Hesp BR, Scandlyn M. Ethical challenges in acknowledging professional writing support. Med Writ. 2020;29(3):60-63.
  14. Nastasee SA. Acknowledgment of medical writers in medical journal articles: a comparison from the years 2000 and 2007. AMWA J. 2010;25(1):2-7.
  15. Jørgensen M, Thomas KB, Zerm M, Paarlberg RA. Protection of personal data and commercially confidential information under the Clinical Trials Regulation (EU) No 536/2014: EMA Revised CTIS Transparency Rules. Med Writ. 2024;33(3):12-21. doi:10.56012/frkj6889.